Cell-based Cancer Immunotherapy, Volume 183 provides the latest progress concerning research on anticancer cellular immunotherapies and their immunological, translation, or clinical aspects. Topics covered in this volume include Methods behind clinical DC vaccine products against glioblastoma, Fully closed and automated isolation of natural blood dendritic cells for cancer immunotherapy, Methods behind Oncolytic virus-based DC vaccines in cancer: towards a multiphase combined treatment strategy for Glioblastoma (GBM) patients, Identification of TCR repertoire patterns linked with anti-cancer immunotherapy, Training of epitope-TCR prediction models with healthy donor-derived cancer-specific T cells, Methods behind neoantigen predictions for anticancer vaccines, Methods behind CD137L-DC-EBV-VAX anticancer vaccine, and much more. Additional sections cover Gold Standard Assessment of Immunogenic Cell Death Induced by Photodynamic Therapy: From In Vitro to Tumor Mouse Models and Anti-Cancer Vaccination Strategies, Methods behind TCR analyses for colorectal cancer-associated TILs, The use of xCELLigence, Incucyte, and/or Cr/LDH/maker-release assays, Humanized mouse models for anti-cancer therapy, In vitro re-challenge of CAR T cells, Methods behind adoptively transferred tumor draining lymphocytes? for anticancer immunotherapy, and A murine glioblastoma platform to test cellular therapies with the standard of care. Provides comprehensive method articles from front-line experts on the topic of anticancer cellular immunotherapiesProvides useful schematic material and cutting-edge discussionsPresents the latest insights and future perspectives on the covered topics, along with their implications for immuno-oncology, as well as clinical perspectives INDICE: 1. Methods behind clinical DC vaccine products against glioblastomaRüdiger V. Sorg2. Fully closed and automated isolation of natural blood dendritic cells for cancer immunotherapyJolanda de Vries and Gerty Schreibelt3. Methods behind Oncolytic virus-based DC vaccines in cancer: towards a multiphase combined treatment strategy for Glioblastoma (GBM) patientsStefaan W. Van Gool4. Identification of TCR repertoire patterns linked with anti-cancer immunotherapyKris Laukens and Romi Vandoren5. Training of epitope-TCR prediction models with healthy donor-derived cancer-specific T cellsEva Lion and Kris Laukens6. Methods behind neoantigen predictions for anticancer vaccinesCedric Bogaert7. Methods behind CD137L-DC-EBV-VAX anticancer vaccineHerbert Schwarz8. Gold Standard Assessment of Immunogenic Cell Death Induced by Photodynamic Therapy: From In Vitro to Tumor Mouse Models and Anti-Cancer Vaccination StrategiesDmitri Krysko9. Methods behind TCR analyses for colorectal cancer-associated TILsSara Verbandt, Ting Pu and Sabine Tejpar10. The use of xCELLigence, Incucyte, and/or Cr/LDH/maker-release assaysAdam Snook11. Humanized mouse models for anti-cancer therapyEleonora Leucci12. In vitro re-challenge of CAR T cellsSebastien Walchli and Alicia Villatoro13. Methods behind adoptively transferred tumor draining lymphocytes? for anticancer immunotherapyHarry D. Bear and Carolyn Haynes14. A murine glioblastoma platform to test cellular therapies with the standard of careAn Coosemans and Aaron Ziani Zeryouh Jr.
- ISBN: 978-0-443-13995-6
- Editorial: Academic Press
- Encuadernacion: Cartoné
- Páginas: 318
- Fecha Publicación: 05/03/2024
- Nº Volúmenes: 1
- Idioma: Inglés